RareKids-CAN Offer Subsidized Services for Investigator-initiated Academic Clinical Trials

RareKids-CAN offers a range of subsidized services for investigator-initiated (academic-led) pediatric rare disease clinical trials. The goal of these services is to stretch project funds further, ensuring greater impact and cost savings. Below is the list of subsidized services offered:

 

100% Subsidized Services (RareKids-CAN will cover 100% of the cost of the following services):

    • Consultations: We will conduct a robust consultation to identify areas of needs for your project with valuable involvement from relevant sub platforms based on your project needs to ensure your project receives adequate support.
    • High-level project management: An experienced project manager will ensure efficient coordination, oversight, and successful execution from inception to completion for your clinical trial.
    • Database build (not including management): We will provide project-specific electronic case report form (e-CRF) development and database management in a validated REDCap database housed at the Women and Children’s Health Research Institute (WCHRI).
    • Data Safety Monitoring Board: From our repository of individuals with specific expertise relevant to your project, we facilitate a centralized data safety monitoring board to ensure participant safety and provide expertise on clinical trial conduct for continuation, modification, or termination.

 

50% Subsidized Services (RareKids-CAN will cover 50% of the total cost of the following services):

    • Regulatory submissions: We assist study teams in the preparation and submission of clinical trial applications, investigational testing authorizations, and single-patient study applications for regulated clinical trials to Health Canada. We will also assist in adverse event reporting.
    • Monitoring: We have a dedicated and experienced monitoring team to perform risk-based remote and on-site monitoring to meet the Health Canada required sponsor obligations.

All other services are 100% cost recovered (i.e., RareKids-CAN will not subsidize)

 

If you have a clinical trial that require these services or would like to further discuss, you can complete the project intake form.

RareKids-CAN logo

Read next...

Application to Collaborative Research Awards

Applications Open for New NMD4C Collaborative Research Training Awards!

The NMD4C is excited to announce a new program for neuromuscular research trainees that will support collaboration opportunities between Canadian research labs.

David Green awards from MDC

NMD4C Members Receive Dr David Green Awards from Muscular Dystrophy Canada

We are excited to share that several NMD4C investigators and members have been honored with a Dr David Green Award from Muscular Dystrophy Canada!

GRIMN logo

Lower Extremity Muscle Strengthening Program in Myotonic Dystrophy Type 1 from Groupe de recherche interdisciplinaire sur les maladies neuromusculaires

The Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN) recently created a video aimed at health professionals that provides an in-depth explanation of the Myotonic dystrophy (DM1) training parameters used in their studies.

2026 Clinical Neuromuscular Fellowship Competition poster

Fifth Annual Clinical Fellowship Competition from NMD4C and MDC Opens May 1st

The NMD4C and MDC clinical neuromuscular fellowship competition is accepting applications for the 2026 competition until June 12, 2025.

poster congratulating King's Medal Recipient

King’s Medal Awarded to Canadian Neuromuscular Clinicans and Researchers

Several NMD4C investigators and collaborators from the Canadian neuromuscular community have been awarded a King Charles III’s Coronation Medal in recognition of their outstanding contributions and service.

Announcement poster reading: New home online for NMD4C community of practice

New Home on NMD4C Website for Community of Practice

Check out the new home for the NMD4C community of practice (CoP), now live on the NMD4C website!